Sikkerhet og effekt av litium hos barn og ungdom med bipolar lidelse: Systematisk oversikt

Safety and efficacy of lithium in children and adolescents: A systematic review in bipolar illness

Amerio, A. Ossola, P. Scagnelli, F. Odone, A. Allinovi, M. Cavalli, A. Iacopelli, J. Tonna, M. Marchesi, C. Ghaemi, S. N.
European Psychiatry
Introduction: Many clinicians are reluctant to use traditional mood-stabilizing agents, especially lithium, in children and adolescents. This review examined the evidence for lithium's safety and efficacy in this population. Methods: A systematic review was conducted on the use of lithium in children and adolescents with bipolar disorder (BD). Relevant papers published through June 30<sup>th</sup> 2018 were identified searching the electronic databases MEDLINE, Embase, PsycINFO and the Cochrane Library. Results: 30 articles met inclusion criteria, including 12 randomized controlled trials (RCTs). Findings from RCTs demonstrate efficacy for acute mania in up to 50% of patients, and evidence of long-term maintenance efficacy. Lithium was generally safe, at least in the short term, with most common side effects being gastrointestinal, polyuria, or headache. Only a minority of patients experienced hypothyroidism. No cases of acute kidney injury or chronic kidney disease were reported. Conclusions: Though the available literature is mostly short-term, there is evidence that lithium monotherapy is reasonably safe and effective in children and adolescents, specifically for acute mania and for prevention of mood episodes. Copyright © 2018 Elsevier Masson SAS

Oversett med Google Translate

Behandling og hjelpetiltak


Psykiske vansker og lidelser

Følelsesmessige problemer

Bipolare lidelser


Medikamentell behandling

Antipsykotisk medisin


Barn i skolealder (6-12 år)

Ungdom (13-18 år)

Mer informasjon
Leter du etter mer informasjon om temaet? Trykk på lenkene nedenfor for å søke i PsykTestBarn og Håndboka for barn og unges psykiske helse.